PMV Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects …

Biotechnology
US, Cranbury [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PMVP's Analysis
CIK: 1699382 CUSIP: 69353Y103 ISIN: US69353Y1038 LEI: - UEI: -
Secondary Listings
PMVP has no secondary listings inside our databases.